ArticleJAMA network open2023

Time-Dependent Changes in Risk of Progression During Use of Bevacizumab for Ovarian Cancer.

Shiro Takamatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.